Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ASF-1057: Phase IIb start

By year end, Astion will begin a double-blind, placebo-controlled, French Phase IIb trial

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE